Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: Resolved issues versus remaining opportunity

被引：5

作者：

Fisher, RI ^{[1
]}

机构：

[1] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14627 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 22期

关键词：

D O I：

10.1200/JCO.2002.20.22.4411

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：4411 / 4412

页数：2

共 14 条

[1]

COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].

FISHER, RI ;

GAYNOR, ER ;

DAHLBERG, S ;

OKEN, MM ;

GROGAN, TM ;

MIZE, EM ;

GLICK, JH ;

COLTMAN, CA ;

MILLER, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006

[2]

Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: Lessons learned and challenges remaining [J].

Fisher, RI .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) :4-5

[3]

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma [J].

Gisselbrecht, C ;

Lepage, E ;

Molina, T ;

Quesnel, B ;

Fillet, G ;

Lederlin, P ;

Coiffier, B ;

Tilly, H ;

Gabarre, J ;

Guilmin, F ;

Hermine, O ;

Reyes, F .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2472-2479

[4]

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-Cell non-Hodgkin's lymphoma: An evidence-based review [J].

Hahn, T ;

Wolff, SN ;

Czuczman, M ;

Fisher, RI ;

Lazarus, HM ;

Vose, J ;

Warren, L ;

Watt, R ;

McCarthy, PL .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (06) :308-331

[5]

COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH SEQUENTIAL CHEMOTHERAPY FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA IN FIRST COMPLETE REMISSION - A STUDY OF 464 PATIENTS [J].

HAIOUN, C ;

LEPAGE, E ;

GISSELBRECHT, C ;

COIFFIER, B ;

BOSLY, A ;

TILLY, H ;

MOREL, P ;

NOUVEL, C ;

HERBRECHT, R ;

DAGAY, MF ;

GAULARD, P ;

REYES, F .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2543-2551

[6]

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study [J].

Haioun, C ;

Lepage, E ;

Gisselbrecht, C ;

Salles, G ;

Coiffier, B ;

Brice, P ;

Bosly, A ;

Morel, P ;

Nouvel, C ;

Tilly, H ;

Lederlin, P ;

Sebban, C ;

Brière, J ;

Gaulard, P ;

Reyes, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3025-3030

[7]

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma [J].

Kaiser, U ;

Uebelacker, L ;

Abel, U ;

Birkmann, J ;

Trümper, L ;

Schmalenberg, H ;

Karakas, T ;

Metzner, B ;

Hossfeld, DK ;

Bischoff, HG ;

Franke, A ;

Reiser, M ;

Müller, P ;

Mantovani, L ;

Grundeis, M ;

Rothmann, F ;

von Seydewitz, CU ;

Mesters, RM ;

Steinhauer, EU ;

Krahl, D ;

Schumacher, K ;

Kneba, M ;

Baudis, M ;

Schmitz, N ;

Pfab, R ;

Köppler, H ;

Parwaresch, R ;

Pfreundschuh, M ;

Havemann, K .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4413-4419

[8]

Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: Randomized phase III EORTC study [J].

Kluin-Nelemans, HC ;

Zagonel, V ;

Anastasopoulou, A ;

Bron, D ;

Roozendaal, KJ ;

Noordijk, EM ;

Musson, H ;

Teodorovic, I ;

Maes, B ;

Carbone, A ;

Carde, P ;

Thomas, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) :22-30

[9]

AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA [J].

PHILIP, T ;

GUGLIELMI, C ;

HAGENBEEK, A ;

SOMERS, R ;

VANDERLELIE, H ;

BRON, D ;

SONNEVELD, P ;

GISSELBRECHT, C ;

CAHN, JY ;

HAROUSSEAU, JL ;

COIFFIER, B ;

BIRON, P ;

MANDELLI, F ;

CHAUVIN, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1540-1545

[10]

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group [J].

Santini, G ;

Salvagno, L ;

Leoni, P ;

Chisesi, T ;

De Souza, C ;

Sertoli, MR ;

Rubagotti, A ;

Congiu, AM ;

Centurioni, R ;

Olivieri, A ;

Tedeschi, L ;

Vespignani, M ;

Nati, S ;

Soracco, M ;

Porcellini, A ;

Contu, A ;

Guarnaccia, C ;

Pescosta, N ;

Majolino, I ;

Spriano, M ;

Vimercati, R ;

Rossi, E ;

Zambaldi, G ;

Mangoni, L ;

Endrizzi, L ;

Sileni, VC ;

Miggiano, MC ;

Marino, G ;

Damasio, E ;

Rizzoli, V .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2796-2802

← 1 2 →